| 49.68 Delayed Data As of 4:00pm ET |  +0.87 / +1.77%Today’s Change | 31.97 Today|||52-Week Range 64.48 | +27.55% Year-to-Date |
| Previous close | 48.82 |
| Today’s open | 49.39 |
| Day’s range | 48.98 - 50.01 |
| Volume | 332,367 |
| Average volume (3 months) | 455,884 |
| Market cap | $2.4B |
| Earnings growth (last year) | +76.88% |
| Earnings growth (this year) | +1,430.88% |
| Earnings growth (next 5 years) | -45.30% |
| Revenue growth (last year) | -15.78% |
| P/E ratio | 4.3 |
| Price/Sales | 101.96 |
| Price/Book | 3.98 |
| Today’s change | Today’s % change | |
|---|---|---|
| RAREUltragenyx Pharmaceu... | -0.72 | -1.69% |
| BHVNBiohaven Pharmaceuti... | +0.10 | +0.22% |
| HCMHutchison China Medi... | +0.93 | +4.86% |
| PTCTPTC Therapeutics Inc | +0.21 | +0.58% |
| Next reporting date | November 6, 2019 |
| EPS forecast (this quarter) | -$1.32 |
| Annual revenue (last year) | $18.0M |
| Annual profit (last year) | -$30.1M |
| Net profit margin | -158.98% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
